The AKT signaling pathway is also important for modulating the sensitivity of renal cancer cells to TKIs, and combination with AKT inhibitor treatment improved the anticancer effect of TKIs in ccRCC 28, 39. The gene discussed is AKT1; the disease is nonpapillary renal cell carcinoma.